Inclusion body myositis (IBM) is often viewed as an enigmatic disease with uncertain
pathogenic mechanisms and confusion around diagnosis, classification and prospects for …

Idiopathic inflammatory myopathies (IIM) include the main subgroups polymyositis (PM),
dermatomyositis (DM), inclusion body myositis (IBM) and juvenile DM (JDM). The mentioned …

The systemic immunity-inflammation index (SII) is a novel inflammatory marker, and aberrant
blood lipid levels are linked to inflammation. This study aimed to look at the probable link …

Cardiovascular involvement in idiopathic inflammatory myopathies (IIM) is an understudied
area which is gaining increasing recognition in recent times. Recent advances in imaging …

Lipid storage myopathies (LSMs) are a heterogeneous group of genetic disorders that
present with abnormal lipid storage in multiple body organs, typically muscle. Patients can …

Background Polymyositis (PM) and dermatomyositis (DM) are severe chronic autoimmune
diseases, characterized by muscle fatigue and low muscle endurance. Conventional …

Objective: This study identifies the health care costs and utilization, as well as comorbidities,
in a Medicare population of inclusion body myositis (IBM) patients. Methods: Medicare …

Objective Damage to the vascular endothelium is strongly implicated in the pathogenesis of
idiopathic inflammatory myopathies (IIM). Normally, high‐density lipoprotein (HDL) protects …

Background Altered lipid metabolism is a feature of systemic autoimmune diseases.
Dyslipidemia is associated with the disease activity and progression in patients with multiple …

We performed a systematic review of cardiovascular risk factors in idiopathic inflammatory
myopathies (IIMs) and their cardiovascular outcomes, including acute coronary syndrome …